A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says
Results of a large clinical trial found the treatment did not work any better than a placebo.
Posted inBrain Documentary Films and Programs Environmental Science & Technology (Journal) Hazardous and Toxic Substances Heart microplastics Movies New England Journal of Medicine Plastics Pollution Research Science (Journal) Science and Technology South by Southwest Music and Media Conference Water Pollution Workplace Hazards and Violations
A New Film at SXSW Warns of the Potential Harm of Microplastics
At SXSW, a documentary traces the arc of plastics in our lives, and highlights evolving research of the potential harm of its presence in our bodies.
Posted inBrain Clinical Trials Depression (Mental) Drug Abuse and Traffic Drug Enforcement Administration Drugs (Pharmaceuticals) Food and Drug Administration Heart Mental Health and Disorders Opioids and Opiates Pain-Relieving Drugs Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Research Therapy and Rehabilitation
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.
Posted inBrain Clinical Trials Depression (Mental) Drug Abuse and Traffic Drug Enforcement Administration Drugs (Pharmaceuticals) Food and Drug Administration Heart Mental Health and Disorders Opioids and Opiates Pain-Relieving Drugs Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Research Therapy and Rehabilitation
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.